Daunomycin-polypeptide conjugates with antitumor activity.
Rita Szabó1, Zoltán Bánóczi, Gábor Mezo
1Research Group of Peptide Chemistry, Hungarian Academy of Sciences, Eötvös L. University, Budapest 112, Hungary.
Biochimica Et Biophysica Acta
|July 28, 2010
Summary
New water-soluble drug conjugates using daunomycin (Dau) coupled to polypeptides, including octaarginine, show improved antitumor activity against leukemia cell lines. Drug delivery and efficacy depend on carrier properties and experimental conditions.
Area of Science:
- Bioconjugation Chemistry
- Pharmacology
- Cancer Biology
Background:
- Daunomycin (Dau) is a potent chemotherapy agent with limitations in solubility and targeted delivery.
- Development of novel drug delivery systems is crucial for enhancing cancer therapeutic efficacy and reducing side effects.
- Polypeptide-based drug conjugates offer potential for improved pharmacokinetics and targeted cancer treatment.
Purpose of the Study:
- To synthesize and characterize novel water-soluble daunomycin (Dau) conjugates.
- To evaluate the in vitro cytotoxicity, cytostatic effects, adhesion, and cellular uptake of these conjugates.
- To investigate the influence of polypeptide carrier properties and cell-penetrating peptides on drug activity.
Main Methods:
- Synthesis of daunomycin (Dau) conjugates with cationic, amphoteric, and anionic branched polypeptides.
- Preparation of a conjugate featuring a cationic polypeptide carrier modified with octaarginine (cell-penetrating peptide).
- In vitro assessment of cytotoxicity, cytostatic effects, adhesion, and cellular uptake using murine and human leukemia cell lines and macrophages.
Main Results:
- The developed drug conjugates demonstrated water solubility.
- Cytotoxicity and cellular uptake were significantly influenced by the polypeptide carrier's properties and experimental conditions (concentration, incubation time).
- Attachment of polypeptide carriers and cell-penetrating peptides enhanced the antitumor activity of daunomycin (Dau) in a cell-line-dependent manner.
Conclusions:
- Water-soluble daunomycin (Dau) conjugates with branched polypeptides and cell-penetrating peptides can be effectively developed.
- The choice of carrier and optimization of experimental conditions are critical for maximizing the therapeutic potential of these conjugates.
- These novel conjugates show promise for improved leukemia treatment by enhancing drug delivery and antitumor efficacy.
Related Concept Videos
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
01:10Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...